Evidence map›Paper›PMID 27467507›Full record

ArticlePloS one2016

Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.

Olga Papadodima, Panagiotis Moulos, Aggeliki Koryllou, Georgia Piroti, Fragiskos Kolisis, Aristotelis Chatziioannou, Vasiliki Pletsa

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Olga PapadodimaInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece.
Panagiotis MoulosInstitute of Molecular Biology and Genetics, Biomedical Sciences Research Centre 'Alexander Fleming', 16672 Vari, Greece.
Aggeliki KoryllouInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece.
Georgia PirotiInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece.
Fragiskos KolisisLaboratory of Biotechnology, School of Chemical Engineering, National Technical University of Athens, 15780 Athens, Greece.
Aristotelis ChatziioannouInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece.
Vasiliki PletsaInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

A549 CellsAlkylating AgentsBlotting, WesternCarcinoma, Non-Small-Cell LungCell DeathCell Line, TumorDacarbazineGene Expression ProfilingGene Expression Regulation, NeoplasticGene OntologyHumansLung NeoplasmsMethylnitrosoureaReverse Transcriptase Polymerase Chain ReactionSignal TransductionTemozolomideAlkylating AgentsDacarbazineMethylnitrosoureaTemozolomide

Identifiers

PMID27467507
PMCPMC4965087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.